ArticleFrontiers in endocrinology2025
Extracellular matrix from decellularized porcine organs as scaffolds for insulin-secreting cells and pancreatic islets.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular Matrix (ECM) from different organs has been used to cultivate several cell types. ECM produced by organ decellularization contains collagens, fibronectin, glycosaminoglycans (GAGs), laminins and other components essential in providing structural support and biochemical cues for cells to attach, function, and proliferate. The organ from which ECM is extracted and produced is hypothesized to play a vital role in cell responses upon recellularization. To investigate this hypothesis, five porcine organs (bladders, kidneys, livers, lungs, and pancreas) were decellularized by a detergent-based method or by detergent-free procedures. Insulin-secreting rat pancreatic β-like cells (INS-1) were first used to screen, over 7 days, the effect of the ECM produced by the tested decellularization techniques from the five selected organs, revealing SDS treatment did not result in cell responsive ECMs for all the tested organs. Detergent-free-derived ECMs, on the other hand, allow cell attachment except for the pancreatic ECM. The biocompatibility of the ECMs made from detergent-free methods was subsequently validated using cell proliferation and cell metabolism assays, immunostaining for insulin and actin expression, as well as glucose-stimulated insulin secretion (GSIS). INS-1 cells proliferated on certain detergent-free ECMs and secreted insulin following 7 days of culture. Further, primary pancreatic mouse islets were isolated and cultivated 48 hours on detergent-free decellularized bladder pieces and histological analysis showed intact islets embedded within the bladder ECM. GSIS revealed functional islets following 48 hours on detergent-free-derived bladder ECM. Islets cultivated on detergent-free-derived bladder ECM expressed insulin, with endothelial cells (i.e., CD31-positive cells) localized at the islet-ECM interface.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.